The BRICS Cancer Chemotherapy Market is supported by improvements in cancer screening, diagnosis, treatment infrastructure, and long-term disease management. The BRICS Cancer Chemotherapy Market size is expected to reach US$ 14,315.4 million by 2031 from US$ 6,140.1 million in 2024. The market is estimated to record a CAGR of 12.9% from 2025 to 2031. Cancer chemotherapy remains an important...